September 30, 2011 — The US Food and Drug Administration (FDA) has granted approval for the use of the NeuRx Diaphragm Pacing System to aid breathing in patients with amyotrophic lateral sclerosis ...
Neurotechnology company Synapse Biomedical has received Humanitarian Device Exemption (HDE) marketing approval from the U.S. Food and Drug Administration for a diaphragm pacing system that helps ...
The ALS Milano-Torino Staging (ALS-MITOS) system can reliably foresee the progress of ALS up to 18 months. The result was published in an issue of Journal of Neurology, Neurosurgery and Psychiatry.
Irvine, Calif. — Applied Medical Resources Corp. is implementing Arburg GmbH + Co.'s ALS host computer system to optimize resources in its Lake Forest, Calif., plant. It took a year of concentrated ...
Amyotrophic lateral sclerosis (ALS) is a condition that causes the degeneration of the nerve cells in the nervous system, affecting certain neurons in the spinal cord. ALS is a fatal disease that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback